Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations

Background: We previously reported that interstitial injection of bleomycin (BLM) reduces the size of early-stage extracranial arteriovenous malformation (AVM). Here, we sought to investigate the potential mechanism of BLM in treating extracranial AVM. Methods: Samples of human extracranial AVM (n=3...

Full description

Bibliographic Details
Main Authors: Congzhen Qiao, Yajing Qiu, Yun Zou, Chen Hua, Yuanbo Li, Yunbo Jin, Xiaoxi Lin
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2021-12-01
Series:Chinese Journal of Plastic and Reconstructive Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2096691121001102
_version_ 1828266536293367808
author Congzhen Qiao
Yajing Qiu
Yun Zou
Chen Hua
Yuanbo Li
Yunbo Jin
Xiaoxi Lin
author_facet Congzhen Qiao
Yajing Qiu
Yun Zou
Chen Hua
Yuanbo Li
Yunbo Jin
Xiaoxi Lin
author_sort Congzhen Qiao
collection DOAJ
description Background: We previously reported that interstitial injection of bleomycin (BLM) reduces the size of early-stage extracranial arteriovenous malformation (AVM). Here, we sought to investigate the potential mechanism of BLM in treating extracranial AVM. Methods: Samples of human extracranial AVM (n=3) with no pharmacological treatment were harvested. AVM endothelial cells were isolated and cultured in primary cell culture. The transcriptome was examined using RNA-sequencing, and differentially expressed C-type lectin domain family 14 member A (CLEC14A) was validated at the transcriptomic and protein levels. Immunocytochemical staining of CLEC14A was performed in samples of human extracranial AVM, with and without BLM treatment. Results: Through second-generation sequencing, we found that the expression of 5 689 genes were differentially increased or decreased following 24-h BLM stimulation. We found that CLEC14A may play an important role in the progression of AVM and can be inhibited by BLM treatment. Conclusion: BLM inhibited CLEC14A expression to attenuate the progression of AVM.
first_indexed 2024-04-13T04:54:01Z
format Article
id doaj.art-1293412168b641168fcaf2c5c90de2a6
institution Directory Open Access Journal
issn 2096-6911
language English
last_indexed 2024-04-13T04:54:01Z
publishDate 2021-12-01
publisher KeAi Communications Co. Ltd.
record_format Article
series Chinese Journal of Plastic and Reconstructive Surgery
spelling doaj.art-1293412168b641168fcaf2c5c90de2a62022-12-22T03:01:34ZengKeAi Communications Co. Ltd.Chinese Journal of Plastic and Reconstructive Surgery2096-69112021-12-0134175180Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformationsCongzhen Qiao0Yajing Qiu1Yun Zou2Chen Hua3Yuanbo Li4Yunbo Jin5Xiaoxi Lin6Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaCorresponding authors. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Huangpu District, Shanghai 200011, China.; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaCorresponding authors. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Huangpu District, Shanghai 200011, China.; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, ChinaBackground: We previously reported that interstitial injection of bleomycin (BLM) reduces the size of early-stage extracranial arteriovenous malformation (AVM). Here, we sought to investigate the potential mechanism of BLM in treating extracranial AVM. Methods: Samples of human extracranial AVM (n=3) with no pharmacological treatment were harvested. AVM endothelial cells were isolated and cultured in primary cell culture. The transcriptome was examined using RNA-sequencing, and differentially expressed C-type lectin domain family 14 member A (CLEC14A) was validated at the transcriptomic and protein levels. Immunocytochemical staining of CLEC14A was performed in samples of human extracranial AVM, with and without BLM treatment. Results: Through second-generation sequencing, we found that the expression of 5 689 genes were differentially increased or decreased following 24-h BLM stimulation. We found that CLEC14A may play an important role in the progression of AVM and can be inhibited by BLM treatment. Conclusion: BLM inhibited CLEC14A expression to attenuate the progression of AVM.http://www.sciencedirect.com/science/article/pii/S2096691121001102BleomycinExtracranial arteriovenous malformationCLEC14ARNA-Sequencing
spellingShingle Congzhen Qiao
Yajing Qiu
Yun Zou
Chen Hua
Yuanbo Li
Yunbo Jin
Xiaoxi Lin
Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
Chinese Journal of Plastic and Reconstructive Surgery
Bleomycin
Extracranial arteriovenous malformation
CLEC14A
RNA-Sequencing
title Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
title_full Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
title_fullStr Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
title_full_unstemmed Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
title_short Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations
title_sort bleomycin inhibits clec14a to attenuate the progression of extracranial arteriovenous malformations
topic Bleomycin
Extracranial arteriovenous malformation
CLEC14A
RNA-Sequencing
url http://www.sciencedirect.com/science/article/pii/S2096691121001102
work_keys_str_mv AT congzhenqiao bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT yajingqiu bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT yunzou bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT chenhua bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT yuanboli bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT yunbojin bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations
AT xiaoxilin bleomycininhibitsclec14atoattenuatetheprogressionofextracranialarteriovenousmalformations